Targeting protein synthesis pathways in MYC-amplified medulloblastoma
Abstract MYC is one of the most deregulated oncogenic transcription factors in human cancers. MYC amplification/or overexpression is most common in Group 3 medulloblastoma and is positively associated with poor prognosis. MYC is known to regulate the transcription of major components of protein synt...
Saved in:
Main Authors: | Devendra Kumar, Ranjana Kanchan, Nagendra K. Chaturvedi |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-025-01761-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres
by: Natália Hogetop Freire, et al.
Published: (2025-01-01) -
Clinical case – medulloblastoma
by: A. Kablytė, et al.
Published: (2018-03-01) -
Aberrant FGF signaling promotes granule neuron precursor expansion in SHH subgroup infantile medulloblastoma
by: Odessa R Yabut, et al.
Published: (2025-01-01) -
Single-Cell RNA Sequencing Reveals LEF1-Driven Wnt Pathway Activation as a Shared Oncogenic Program in Hepatoblastoma and Medulloblastoma
by: Christophe Desterke, et al.
Published: (2025-01-01) -
Development of a simple prediction model for tracheostomy requirement after surgical resection of medulloblastoma in children
by: Sina Zoghi, et al.
Published: (2025-01-01)